RecruitingNot applicableNCT06891755
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Sponsor: Apreo Health, Inc.
Houston, TX · +17 more sites
COPD clinical trials in Houston, TX
17 recruiting copd studies with a site in Houston, TX.
RecruitingPhase 3NCT07190209
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Allen, TX · Beaumont, TX · Bellaire, TX · +72 more sites
RecruitingPhase not listedNCT04302272
STRIVE Post-Market Registry Study
Sponsor: Olympus Corporation of the Americas
Dallas, TX · Houston, TX · +13 more sites
RecruitingPhase not listedNCT07612878
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
Sponsor: Sanofi
Houston, TX · Kingwood, TX · North Richland Hills, TX · +4 more sites
RecruitingPhase 3NCT06878261
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
Sponsor: AstraZeneca
Boerne, TX · El Paso, TX · Houston, TX · +77 more sites
RecruitingPhase 2NCT07759245
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Eli Lilly and Company
Denison, TX · Houston, TX · Lewisville, TX · +15 more sites
RecruitingPhase 3NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Sponsor: GlaxoSmithKline
Corsicana, TX · Dallas, TX · Houston, TX · +39 more sites
RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Austin, TX · Dallas, TX · El Paso, TX · +54 more sites
RecruitingPhase 3NCT06283966
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Abilene, TX · Amarillo, TX · Austin, TX · +232 more sites
RecruitingPhase 3NCT07190222
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Austin, TX · Dallas, TX · Denison, TX · +73 more sites
RecruitingPhase 2NCT07082738
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Boerne, TX · Dallas, TX · Denison, TX · +83 more sites
RecruitingPhase 2NCT07059091
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Sponsor: Johns Hopkins University
Houston, TX · +22 more sites
RecruitingPhase 3NCT06883305
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Sponsor: AstraZeneca
Dallas, TX · Forney, TX · Fort Worth, TX · +70 more sites
RecruitingPhase 2 / Phase 3NCT07363694
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Sponsor: Pfizer
Boerne, TX · Carrollton, TX · Cypress, TX · +58 more sites
RecruitingPhase 3NCT07177339
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Sponsor: GlaxoSmithKline
Dallas, TX · DeSoto, TX · Greenville, TX · +39 more sites
RecruitingPhase not listedNCT06122077
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Sponsor: Freenome Holdings Inc.
Houston, TX · Tyler, TX · +34 more sites
RecruitingNot applicableNCT05204888
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Sponsor: Temple University
Houston, TX · +24 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.